5α-Reductase Inhibitors: A New Hope in Dermatology?

    Boaz Amichai, Marcelo H. Grunwald, Richard Sobel
    Image of study
    TLDR Finasteride shows promise for treating hair loss and excessive hair growth, but more research is needed to confirm its effectiveness and safety.
    The document from 1997 discusses the potential of finasteride, a 5α-reductase inhibitor, in treating male-pattern baldness, hirsutism, and acne by reducing dihydrotestosterone (DHT) levels. Significant decreases in DHT and hair growth were observed in studies on hirsute women, and animal studies indicated increased hair weight in male-pattern baldness, with a decrease in scalp DHT concentration also noted in human males. The effect of finasteride on acne remains uncertain. Preliminary results are promising, but more research is needed to fully assess the benefits and risks of 5α-reductase inhibitors in dermatology. Side effects of finasteride include sexual dysfunction and increased serum cholesterol in women using oral contraceptives, and it is contraindicated in pregnancy due to the risk of male fetal genital abnormalities.
    Discuss this study in the Community →

    Research cited in this study

    12 / 12 results

    Related Community Posts Join

    6 / 630 results

    Similar Research

    5 / 1000+ results
      Antiandrogens and Androgen Inhibitors in Dermatologic Treatments

      research Antiandrogens and Androgen Inhibitors in Dermatologic Treatments

      November 2020 in “Elsevier eBooks”
      Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.
      Dermatologic Manifestations of Polycystic Ovary Syndrome

      research Dermatologic Manifestations of Polycystic Ovary Syndrome

      76 citations, January 2007 in “American Journal of Clinical Dermatology”
      Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.
      Selective Non-Steroidal Inhibitors of 5α-Reductase Type 1

      research Selective Non-Steroidal Inhibitors of 5α-Reductase Type 1

      49 citations, January 2004 in “Journal of steroid biochemistry and molecular biology/˜The œJournal of steroid biochemistry and molecular biology”
      Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.